Premium
Bayesian decision sequential analysis with survival endpoint in phase II clinical trials
Author(s) -
Zhao Lili,
Woodworth George
Publication year - 2009
Publication title -
statistics in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.996
H-Index - 183
eISSN - 1097-0258
pISSN - 0277-6715
DOI - 10.1002/sim.3544
Subject(s) - frequentist inference , early stopping , optimal stopping , bayesian probability , bayes' theorem , sequential analysis , stopping rule , computer science , bayes factor , event (particle physics) , stopping time , statistics , decision rule , sequential probability ratio test , mathematics , bayesian inference , mathematical optimization , artificial intelligence , physics , quantum mechanics , artificial neural network
Chen and Chaloner ( Statist. Med. 2006; 25 :2956–2966. DOI: 10.1002/sim.2429 ) present a Bayesian stopping rule for a single‐arm clinical trial with a binary endpoint. In some cases, earlier stopping may be possible by basing the stopping rule on the time to a binary event. We investigate the feasibility of computing exact, Bayesian, decision‐theoretic time‐to‐event stopping rules for a single‐arm group sequential non‐inferiority trial relative to an objective performance criterion. For a conjugate prior distribution, exponential failure time distribution, and linear and threshold loss structures, we obtain the optimal Bayes stopping rule by backward induction. We compute frequentist operating characteristics of including Type I error, statistical power, and expected run length. We also briefly address design issues. Copyright © 2009 John Wiley & Sons, Ltd.